PHARMOPSIS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMOPSIS
Largest movements
- Receivables within one year +€35,141
up €35,141 (+5.7%), from €621,670 to €656,811
of which Other amounts receivable: +€25,119
- Tangible fixed assets -€13,464
down €13,464 (-30.5%), from €44,136 to €30,672
of which Furniture and vehicles: -€9,283
- Cash -€13,343
down €13,343 (-69.2%), from €19,273 to €5,929
mainly Receivables within one year (-€35,141) and Net result for the year (-€32,991)
- Other debts +€35,439
up €35,439 (+177%), from €20,051 to €55,490
- Reserves -€29,138
down €29,138 (-4.7%), from €624,209 to €595,072
- Tax, wage and social debts +€9,475
up €9,475 (+70.5%), from €13,439 to €22,914
- Gross operating margin -€33,415
down €33,415 (-83.8%), from €39,858 to €6,442
- Taxes +€4,560
up €4,560 (+24.1%), from €18,928 to €23,488
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €689,247 | €698,486 | +€9,239 | +1.3% |
| Fixed assets | 21/28 | €44,991 | €31,527 | -€13,464 | -29.9% |
| Tangible fixed assets | 22/27 | €44,136 | €30,672 | -€13,464 | -30.5% |
| Plant, machinery and equipment | 23 | €5,192 | €1,012 | -€4,181 | -80.5% |
| Furniture and vehicles | 24 | €38,944 | €29,660 | -€9,283 | -23.8% |
| Financial fixed assets | 28 | €855 | €855 | = | 0.0% |
| Current assets | 29/58 | €644,257 | €666,959 | +€22,702 | +3.5% |
| Amounts receivable within one year | 40/41 | €621,670 | €656,811 | +€35,141 | +5.7% |
| Trade receivables | 40 | €74,814 | €84,836 | +€10,022 | +13.4% |
| Other amounts receivable | 41 | €546,856 | €571,975 | +€25,119 | +4.6% |
| Cash at bank and in hand | 54/58 | €19,273 | €5,929 | -€13,343 | -69.2% |
| Deferred charges and accrued income | 490/1 | €3,314 | €4,219 | +€905 | +27.3% |
| Total equity and liabilities | 10/49 | €689,247 | €698,486 | +€9,239 | +1.3% |
| Equity | 10/15 | €626,209 | €593,219 | -€32,991 | -5.3% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €624,209 | €595,072 | -€29,138 | -4.7% |
| Distributable reserves | 133 | €624,209 | €595,072 | -€29,138 | -4.7% |
| Profit (loss) carried forward | 14 | - | -€3,853 | -€3,853 | |
| Amounts payable | 17/49 | €63,038 | €105,267 | +€42,229 | +67.0% |
| Amounts payable after more than one year | 17 | €22,777 | €16,055 | -€6,722 | -29.5% |
| Financial debts | 170/4 | €22,777 | €16,055 | -€6,722 | -29.5% |
| Amounts payable within one year | 42/48 | €39,971 | €88,923 | +€48,952 | +122% |
| Current portion of amounts payable after more than one year | 42 | €6,481 | €10,519 | +€4,038 | +62.3% |
| Taxes, remuneration and social security | 45 | €13,439 | €22,914 | +€9,475 | +70.5% |
| Taxes | 450/3 | €13,439 | €22,914 | +€9,475 | +70.5% |
| Other amounts payable | 47/48 | €20,051 | €55,490 | +€35,439 | +177% |
| Accrued charges and deferred income | 492/3 | €290 | €290 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,539 | €13,464 | -€76 | -0.6% |
| Other operating charges | 640/8 | €525 | €180 | -€345 | -65.7% |
| Gross operating margin | 9900 | €39,858 | €6,442 | -€33,415 | -83.8% |
| Operating profit (loss) | 9901 | €25,793 | -€7,201 | -€32,994 | |
| Financial income | 75/76B | €0 | €175 | +€175 | +46,082% |
| Recurring financial income | 75 | €0 | €175 | +€175 | +46,082% |
| Financial charges | 65/66B | €2,269 | €2,477 | +€208 | +9.2% |
| Recurring financial charges | 65 | €2,269 | €2,477 | +€208 | +9.2% |
| Profit (loss) for the period before taxes | 9903 | €23,524 | -€9,503 | -€33,027 | |
| Income taxes | 67/77 | €18,928 | €23,488 | +€4,560 | +24.1% |
| Profit (loss) for the period | 9904 | €4,596 | -€32,991 | -€37,587 | |
| Profit (loss) for the period to be appropriated | 9905 | €4,596 | -€32,991 | -€37,587 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.